首页> 外国专利> MARKER GENES FOR DETERMINING RENAL TOXICITY

MARKER GENES FOR DETERMINING RENAL TOXICITY

机译:确定肾脏毒性的标记基因

摘要

Methods are disclosed for fast and accurate readout of kidney toxicity before it occurs and before it is demonstrated by histopathology examination. Ultimately this approach shall allow earlier compound selection. The twelve genes identified, namely Calbindin-D28k, KIM-1, OPN, EGF, Clusterin, VEGF, OAT-K1, Aldolase A, Aldolase B, Podocin, Alpha-2u and C4, were grouped and ultimately can be assessed in the form of a kit using PCR, a high throughput technology, in order to characterize and rank new compounds according to their anticipated general kidney toxicity. Also disclosed are methods for identifying agents useful in the treatment of kidney disease, methods for monitoring the efficacy of a treatment for kidney disease and kidney-specific vectors including the sequences of the disclosed genes, and a method for identifying a candidate gene associated with a biological process including kidney function.
机译:公开了在肾脏毒性发生之前和通过组织病理学检查证实之前快速和准确读出肾脏毒性的方法。最终,该方法应允许较早的化合物选择。鉴定出的十二个基因,即Calbindin-D28k,KIM-1,OPN,EGF,Clusterin,VEGF,OAT-K1,Aldolase A,Aldolase B,Podocin,Alpha-2u和C4进行了分组,最终可以采用以下形式评估使用PCR(一种高通量技术)对试剂盒进行分析,以根据预期的一般肾脏毒性来对新化合物进行表征和分级。还公开了鉴定用于治疗肾脏疾病的药物的方法,监测治疗肾脏疾病和包括所公开基因的序列的肾脏特异性载体的功效的方法,以及鉴定与肾病相关的候选基因的方法。生物学过程包括肾功能。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号